Loading...
558 Asia Pharmaceuticals Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: B. Braun Melsungen AG, Nutricia, Abbott, Nestlé, Baxter
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc, Aspen Holdings, Baxter International, Fresenius SE & Co. KGaA, B. Braun SE
Country Covered: Australia
Study Period: 2021 - 2029
Major Players: Abbvie Inc., Amgen Inc., AstraZeneca plc, Eli Lilly & Co., Pfizer Inc.
Country Covered: South Korea
Study Period: 2019 - 2029
Major Players: AbbVie Inc., AstraZeneca plc, Bayer AG, SAMSUNG PHARM. Co., LTD., GlaxoSmithKline plc
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Cook Group Incorporated, Integra LifeSciences Corporation, Medtronic PLC, Smith & Nephew plc (Osiris Therapeutics), AbbVie (Allergan plc)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Region Covered: Asia
Study Period: 2019-2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Glaxosmithkline Plc, Bristol-Myers Squibb, Sanofi, Eli Lilly, AstraZeneca Plc
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb
Country Covered: India
Study Period: 2019 - 2029
Major Players: Aurobindo Pharma, Lupin Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd
Country Covered: India
Study Period: 2019 - 2029
Major Players: Dabur India Ltd, Himalaya Wellness, Sydler Remedies Pvt Ltd, Baidyanath, Patanjali Ayurved Limited
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark
Country Covered: India
Study Period: 2021 - 2029
Major Players: Sun Pharmaceutical Industries Limited, Cipla Pharmaceuticals, Pfizer, Lupin, Dr. Reddy’s laboratories
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Country Covered: India
Study Period: 2021 - 2029
Major Players: Emami Limited, Dabur India Limited, Procter & Gamble, Abbott Laboratories, GlaxoSmithKline PLC
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: GlaxoSmithKline PLC, Johnson & Johnson, Boehringer Ingelheim International GmbH, Procter & Gamble, Sanofi SA
_Drugs_Market_1.webp)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Region Covered: Asia
Study Period: 2019-2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Country Covered: Japan
Study Period: 2018 - 2029
Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: Indonesia
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca
Country Covered: South Korea
Study Period: 2021- 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex Inc, Medtronic PLC
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Takeda Pharmaceutical Company Limited, Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Merck & Co., Inc., Daiichi Sankyo Company, Limited
Country Covered: Thailand
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Filter Reports
By Countries
